Answers are grounded in this paper and cite their sources.
Introduction Carbapenemase producing Carbapenem-Resistant Enterobacterales (CP-CRE) pose a growing threat in the UK, with increasing prevalence in recent years associated with higher morbidity, mortality and healthcare costs. This review synthesises evidence in the prevalence of CP-CRE in UK healthcare and community settings. Methods A systematic review was conducted across major five databases and two preprint websites until 14.02.2024. Eligible records were assessed in Covidence, with metadata extracted and quality evaluated using an adapted Newcastle-Ottawa Scale. Pooled CP-CRE prevalence rates with 95% confidence intervals were assessed using ChI 2 and I 2 , where the Q statistic followed an X 2 distribution (with k-1 degrees of freedom). Publication bias was evaluated using Egger's test and funnel plot, with sensitivity analyses performed. Results Among 1,344 screened records, 32 studies were included. The overall pooled prevalence of CRE and CPE in healthcare settings was 1.17% (95%Cl 0.29%-2.51%, I 2 = 99.70%, n-171,107) and 1.06% (95%Cl 0.59%-1.64%; I 2 = 97.60, n=263,833), respectively. CPE pooled prevalence was higher in healthcare carriage samples at 1.23% (95%Cl: 0.68%-1.91%; I 2 =98.10%; n=262,524) than infection samples at 0.03% (95%Cl: 0.00%-0.37%; I 2 =0.00%; n=888). Risk-based admission screening identified a higher CPE proportion of 1.27% (95%Cl: 0.97%-1.60%; I 2 67.30%; n=24,763) compared to universal hospital screening at 0.82% (95%Cl: 0.28%-1.65%; I 2 = 97.90%; n=232,033). In the community, only two studies reported CPE prevalence (0.11%; 95%Cl: 0.00%-0.79%; I 2 =52.60; n=2,630) from carriage samples using point prevalence surveys, showing low prevalence. Conclusion This review provides an overview of CP-CRE prevalence across healthcare and community settings in the UK. Our findings support the national surveillance of CP-CRE in the UK, enabling more targeted screening efforts for CP-CRE detection.
No takes yet. Share an insight, caveat, or question.
Almadhoon et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: